Cardiothoracic & vascular anesthesia

Effect of Liposomal Bupivacaine for Preoperative Thoracic Paravertebral Blockade on Postoperative Pain Following Video-Assisted Thoracoscopic Lung Surgery: A Prospective, Double-Blind, Randomized Controlled Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

Liposomal bupivacaine provided early analgesia comparable to ropivacaine in TPVB for thoracoscopic surgery, but delivered distinct delayed-phase benefits: superior cough-pain control at 72 h, reduced chronic pain scores at 1-3 months, and sustained opioid-sparing effects from 12 to 72 h postoperatively.

Study context

Population
Adults scheduled for elective thoracoscopic lung resection
Participants
60 adults
Comparison
Liposomal bupivacaine vs Ropivacaine
Primary endpoint
VAS score at rest and dynamic
Follow-up
Within 72 hours postoperatively
Methodological detailsprospective, double-blind, single-centre
  • Prospective
  • Double-blind
  • Single-centre

Primary result

As reported in the abstract

Dynamic cough VAS score · 72 h postoperatively

Liposomal bupivacaine

2.37

± 0.56

Ropivacaine

3.10

± 0.82

P < 0.001

Secondary outcomes

Numerical rating scale (NRS) scores, sufentanil consumption, PCA demands, chronic pain scores

Lower NRS scores at 36 h and 72 h with liposomal bupivacaine
Decreased sufentanil consumption from 12 to 72 h with liposomal bupivacaine
Fewer PCA demands at 72 h with liposomal bupivacaine
Lower chronic pain scores at 1-3 months postoperatively with liposomal bupivacaine

Recovery quality

No significant intergroup difference (p > 0.05)

Safety

OutcomeP value
PONVHigher incidence with liposomal bupivacaineP < 0.05

Other complications

No significant intergroup differences (p > 0.05)

Original publication

Effect of Liposomal Bupivacaine for Preoperative Thoracic Paravertebral Blockade on Postoperative Pain Following Video-Assisted Thoracoscopic Lung Surgery: A Prospective, Double-Blind, Randomized Controlled Trial. J Cardiothorac Vasc Anesth. Published 22 September 2025. doi:10.1053/j.jvca.2025.09.040

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.